drugset / Trial / NCT01306786
Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication
RandomizedCrossoverOpen-labelTreatment
Summary
The aim of this randomized trial is to compare the efficacy and tolerability of H. pylori eradication with a 5-day quadruple therapy versus a clarithromycin-containing triple therapy.
Timeline
- Start
- 2008-11
- Primary completion
- 2010-10
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 1 g | — |
| Comparator | Bismuth subcitrate | Unknown | 120 mg | — |
| Comparator | Clarithromycin | Small molecule | 500 mg | — |
| Comparator | Esomeprazole | Small molecule | 20 mg | — |
| Comparator | Metronidazole | Small molecule | 250 mg | — |
| Comparator | Tetracycline | Unknown | 250 mg | — |